Responses
Poster Presentation
Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.
